224 related articles for article (PubMed ID: 4151694)
1. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG
Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
[No Abstract] [Full Text] [Related]
2. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Meier J
Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
[No Abstract] [Full Text] [Related]
3. [Comparative pharmacokinetics of beta-blockers].
Kiechel JR; Meier J
Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
[No Abstract] [Full Text] [Related]
4. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
Pfeifer S; Zimmer C
Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
Regårdh CG
Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
[No Abstract] [Full Text] [Related]
6. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Rigby JW; Scott AK; Hawksworth GM; Petrie JC
Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
[TBL] [Abstract][Full Text] [Related]
9. Overdosage with beta-adrenergic blocking agents.
Prichard BN; Battersby LA; Cruickshank JM
Adverse Drug React Acute Poisoning Rev; 1984; 3(2):91-111. PubMed ID: 6152377
[No Abstract] [Full Text] [Related]
10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect.
Gugler R; Bodem G; Dengler HJ
Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758
[TBL] [Abstract][Full Text] [Related]
12. High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Riant P; Urien S; Albengres E; Duche JC; Tillement JP
Biochem Pharmacol; 1986 Dec; 35(24):4579-81. PubMed ID: 2878668
[No Abstract] [Full Text] [Related]
13. Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
Meier J
Cardiology; 1979; 64 Suppl 1():1-13. PubMed ID: 42483
[No Abstract] [Full Text] [Related]
14. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
[No Abstract] [Full Text] [Related]
15. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Caldwell GW; Easlick SM; Gunnet J; Masucci JA; Demarest K
J Mass Spectrom; 1998 Jul; 33(7):607-14. PubMed ID: 9692244
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson DG
Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
[No Abstract] [Full Text] [Related]
17. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
18. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
[No Abstract] [Full Text] [Related]
19. Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.
Collste P; Borg KO; Aström H; von Bahr C
Clin Pharmacol Ther; 1979 Apr; 25(4):416-22. PubMed ID: 34497
[No Abstract] [Full Text] [Related]
20. The pharmacokinetic properties of beta adrenoceptor blocking drugs.
Gugler R
Arch Int Pharmacodyn Ther; 1980; Suppl():27-31. PubMed ID: 6106455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
